Ashwagandha for Women: What It Actually Does to Cortisol (And What It Doesn't)
You fall asleep fine. Four hours later you're awake — heart going, mind sprinting through tomorrow, body wired in a way that has nothing to do with how tired you are.
If you've searched for a fix, you've met ashwagandha. It's on every shelf, in every gummy, and in roughly nine out of ten wellness videos about cortisol. Which is exactly why it's worth separating what the clinical literature supports from what the internet has decided it does.
Here's the honest version.
Key takeaways
- Ashwagandha is an adaptogen — a plant studied for its effect on the body's stress response system, not on any single symptom.
- The cortisol evidence is the strongest part of the file. Multiple meta-analyses of randomised controlled trials find meaningful reductions in serum cortisol versus placebo.
- The "I feel less stressed" evidence is less settled. A 2025 systematic review found cortisol dropped without a matching change in perceived stress scores.
- Studied doses cluster between 125 mg and 600 mg daily of a standardised root extract, usually over 8–12 weeks.
- Standardisation matters more than milligrams. A "10:1 extract" describes how much herb went in, not how much active compound came out.
What ashwagandha actually is
Withania somnifera is a small shrub in the nightshade family, used in Ayurvedic medicine for roughly three thousand years. The Sanskrit name translates, unglamorously, to "smell of horse" — a reference to the root's scent, and to the strength it was believed to confer.
Modern interest centres on a group of steroidal lactones called withanolides. These are the compounds that appear to act on the hypothalamic–pituitary–adrenal axis, the loop that governs how your body launches and stands down from a stress response.
That last part is the point. Ashwagandha isn't a sedative. It doesn't switch anything off. What the research examines is whether it helps a stress response that has been running too hot for too long return to baseline.
The cortisol question
Cortisol is not the villain the internet has made it. It is the hormone that gets you out of bed, mobilises glucose, and carries you through a genuinely demanding day. It is supposed to peak in the first hour after waking and taper across the day, bottoming out around midnight.
The problem is rhythm, not presence. Under sustained load, that curve flattens or inverts — low in the morning when you need it, climbing at 2 or 3 AM when you don't. That is the mechanism behind the wide-awake-at-3-AM experience so many women describe in their late thirties and forties, and it is why "just sleep more" is such useless advice.
What the trials found
A frequently cited meta-analysis of ashwagandha supplementation reported a significant reduction in serum cortisol against placebo (mean difference −2.58 µg/dL, 95% CI −4.99 to −0.16), alongside improvements on the Perceived Stress Scale and the Hamilton Anxiety Scale.
Then the nuance. A 2025 systematic review and meta-analysis by Albalawi and colleagues, published in Nutrition and Health, came to a split verdict its authors titled bluntly: significant cortisol reduction, but no effect on perceived stress. Same molecule, two different questions, two different answers.
This matters, and most marketing skips it. The biochemical signal is more consistent than the subjective one. Anyone telling you ashwagandha is a settled cure for feeling stressed is reading one half of the literature.
Sleep
The sleep evidence is more encouraging than the perceived-stress evidence. Randomised trials — including work by Langade and colleagues in Cureus — have reported improvements in PSQI sleep-quality scores, time taken to fall asleep, and total sleep time against placebo, generally over 6 to 10 weeks.
The proposed mechanism is indirect and, frankly, more interesting than a sedative effect: if the nocturnal cortisol curve is what's waking you, lowering it addresses the cause rather than sandbagging the symptom.
Ashwagandha and the perimenopause window
Most ashwagandha research was conducted in "chronically stressed adults" rather than specifically in perimenopausal women. That is a real limitation and worth naming.
But there's a reason it keeps appearing in women's hormone formulas, and it isn't marketing. Cortisol and the sex hormones share signalling architecture. Chronic cortisol elevation suppresses progesterone and disrupts the hypothalamic–pituitary–gonadal axis — the same command centre already losing its estrogen buffer during perimenopause. Two stressed systems, one shared wiring loom.
One trial does put ashwagandha directly in this population. In a 2025 randomised, double-blind, three-arm, placebo-controlled study in Frontiers in Reproductive Health (Ademola et al., PMID 41394012), 135 women aged 45–65 took either shatavari root extract 300 mg, shatavari 300 mg plus ashwagandha 250 mg, or placebo, for 8 weeks.
Both active arms improved Menopause Rating Scale scores by roughly 13 points, against 3.26 for placebo (p < 0.0001). Just as importantly, estradiol, FSH, LH and testosterone were unchanged across all three groups — the botanicals did not move hormone levels.
We cover that trial in detail in our guide to shatavari.
How much, and for how long
Studied daily doses of standardised root extract run from 125 mg to 600 mg, with 250–600 mg the most common range in stress and sleep trials. More is not better; a dose-response trial comparing 125, 250 and 500 mg over 8 weeks did not find a clean linear benefit.
Two things matter more than the headline number:
1. Standardisation. This is the part nobody explains. A label reading "ashwagandha extract 10:1" tells you ten kilos of root produced one kilo of extract. It tells you nothing about withanolide content — the compounds the trials were actually measuring. Clinical trials almost universally used extracts standardised to a stated withanolide percentage (commonly
5%). A 10:1 extract and a 5%-withanolide extract at the same milligram figure are not the same input.
2. Time. Trials run 8 to 12 weeks. The reported effects are not next-day effects. If you're evaluating anything in this category after four days, you're evaluating a placebo response.
Safety, and who should skip it
Ashwagandha is generally well tolerated in trials, with mild and infrequent side effects — digestive upset, drowsiness, headache. Long-term safety data beyond a few months is thinner than the enthusiasm around it would suggest.
Talk to a clinician before taking it if you are:
- pregnant or breastfeeding
- on thyroid medication (ashwagandha may influence thyroid hormone levels)
- taking sedatives, benzodiazepines or immunosuppressants
- managing an autoimmune condition
- scheduled for surgery within two weeks
It's a nightshade, so anyone reactive to that family should approach carefully. Rare cases of liver injury have been reported in the literature, which is one more reason to buy from brands that publish third-party testing.
Frequently asked questions
Does ashwagandha lower cortisol? Multiple meta-analyses of randomised controlled trials report statistically significant reductions in serum cortisol compared with placebo. Whether that translates into feeling less stressed is less consistent across studies.
How long does ashwagandha take to work? Clinical trials typically measure outcomes at 8 to 12 weeks. Studies reporting sleep changes generally did so from week 6 onward.
Can I take ashwagandha with HRT? There's no established interaction, but this is a question for your prescriber, not a blog post. Ashwagandha is not a hormone and is not a substitute for hormone therapy.
Morning or night? Trials have used both, and split dosing. If your primary interest is sleep, evening dosing is the more common protocol.
Is ashwagandha safe long term? Most trials run 8–12 weeks. Robust multi-year safety data doesn't yet exist, which is worth factoring into how you use it.
Where ashwagandha sits in AROSE Happy Harmony
AROSE Happy Harmony is a daily gummy for women navigating the perimenopause and menopause transition. Each 3-gummy serving contains 250 mg of ashwagandha root extract (10:1) — inside the range used in stress and cortisol research — alongside 250 mg shatavari, 200 mg maca extract, 150 mg sage, 150 mg fennel, 100 mg chamomile, 75 mg chaste tree berry, 28 mg standardised saffron extract and vitamin B6.
Two things we'd rather say plainly than bury:
Every dose is printed on the label. No proprietary blends, no "herbal complex 800 mg" hiding a token pinch of the expensive ingredient. You can compare our numbers against the trials above, which is the entire point of publishing them.
Our ashwagandha is a 10:1 extract, not a withanolide-standardised one. The dose matches the research; the extract form doesn't yet. We're working on that, and we'd rather tell you than let a milligram figure imply something it shouldn't.
Happy Harmony is formulated to support a healthy stress and cortisol response, hormone balance, mood and restful sleep.* It contains no hormones — and in the trial of its two lead botanicals, hormone levels were unchanged.
* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
This article is educational and is not medical advice. Fennel, chaste tree berry and sage act on estrogen pathways — do not use if pregnant, breastfeeding, or with an estrogen-sensitive condition without speaking to your doctor first.
